Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $5,250 | 4 | 68.2% |
| Consulting Fee | $1,650 | 1 | 21.4% |
| Travel and Lodging | $416.46 | 1 | 5.4% |
| Food and Beverage | $376.07 | 4 | 4.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $7,466 | 7 | $0 (2019) |
| Dendreon Pharmaceuticals LLC | $226.29 | 3 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2019 | $4,206 | 5 | PFIZER INC. ($3,980) |
| 2018 | $1,686 | 3 | PFIZER INC. ($1,686) |
| 2017 | $1,800 | 2 | PFIZER INC. ($1,800) |
All Payment Transactions
10 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/10/2019 | PFIZER INC. | MYLOTARG (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $780.00 | General |
| Category: ONCOLOGY | ||||||
| 06/26/2019 | PFIZER INC. | MYLOTARG (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $3,200.00 | General |
| Category: ONCOLOGY | ||||||
| 05/02/2019 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $74.62 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 05/02/2019 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $36.43 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 04/16/2019 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $115.24 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 12/04/2018 | PFIZER INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $940.00 | General |
| 08/01/2018 | PFIZER INC. | MYLOTARG (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $330.00 | General |
| Category: ONCOLOGY | ||||||
| 03/13/2018 | PFIZER INC. | — | Travel and Lodging | In-kind items and services | $416.46 | General |
| 12/29/2017 | PFIZER INC. | — | Consulting Fee | Cash or cash equivalent | $1,650.00 | General |
| 12/07/2017 | PFIZER INC. | MYLOTARG (Drug) | Food and Beverage | In-kind items and services | $149.78 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 3 | 159 | 241 | $107,954 | $18,954 |
| 2021 | 6 | 314 | 657 | $285,473 | $57,937 |
| 2020 | 6 | 302 | 658 | $160,946 | $47,442 |
All Medicare Procedures & Services
15 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 124 | 206 | $85,696 | $13,873 | 16.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 24 | 24 | $13,920 | $3,817 | 27.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 11 | 11 | $8,338 | $1,264 | 15.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 170 | 472 | $194,910 | $35,958 | 18.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 37 | 37 | $21,460 | $6,210 | 28.9% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 30 | 44 | $26,389 | $5,227 | 19.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 28 | 55 | $14,355 | $4,855 | 33.8% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 30 | 30 | $22,431 | $4,416 | 19.7% |
| 38222 | Diagnostic aspirations and biopsies of bone marrow | Facility | 2021 | 19 | 19 | $5,928 | $1,272 | 21.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 178 | 501 | $102,643 | $29,584 | 28.8% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 31 | 31 | $17,980 | $5,373 | 29.9% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Facility | 2020 | 30 | 30 | $13,470 | $4,288 | 31.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 21 | 41 | $10,701 | $3,661 | 34.2% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 30 | 42 | $12,096 | $3,648 | 30.2% |
| 38222 | Bone marrow biopsy and aspiration | Facility | 2020 | 12 | 13 | $4,056 | $887.23 | 21.9% |
About Dr. Sucha Nand, MD
Dr. Sucha Nand, MD is a Hematology & Oncology healthcare provider based in Maywood, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/28/2005. The National Provider Identifier (NPI) number assigned to this provider is 1134106404.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sucha Nand, MD has received a total of $7,693 in payments from pharmaceutical and medical device companies, with $4,206 received in 2019. These payments were reported across 10 transactions from 2 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($5,250).
As a Medicare-enrolled provider, Nand has provided services to 775 Medicare beneficiaries, totaling 1,556 services with total Medicare billing of $124,333. Data is available for 3 years (2020–2022), covering 15 distinct procedure/service records.
Practice Information
- Specialty Hematology & Oncology
- Location Maywood, IL
- Active Since 12/28/2005
- Last Updated 03/04/2010
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1134106404
Products in Payments
- MYLOTARG (Biological) $4,310
- PROVENGE (Drug) $226.29
- MYLOTARG (Drug) $149.78
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Maywood
Mohamad Khair Khasawneh, Md, MD
Hematology & Oncology — Payments: $1.1M
Dr. Stephanie Tsai, M.d, M.D
Hematology & Oncology — Payments: $141,544
Agne Paner, M.d, M.D
Hematology & Oncology — Payments: $131,263
Patrick Hagen, M.d., M.p.h, M.D., M.P.H
Hematology & Oncology — Payments: $118,454
Joseph Clark, Md, MD
Hematology & Oncology — Payments: $102,053
Scott Smith, Md Phd, MD PHD
Hematology & Oncology — Payments: $101,319